Sleep Disorders Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 or older, of any gender, with no upper age limit
- People who have already been recommended to have an overnight sleep study (called a polysomnography) as part of their normal medical care, for any reason
- People who typically sleep at least 6 hours per night, as required for the type of sleep study being used
- People who are covered by social security or an equivalent health system, where this is required by local rules
- People who have freely agreed to take part and have given both spoken and written consent after being informed about the study
Who may not be able to join:
- People who have an active implanted medical device in their body, such as a pacemaker or an electrical brain stimulator
- People whose chest shape or structure would make it impossible to place a smartphone flat on their chest properly
- People with a psychiatric condition that is not currently under control and that would affect their ability to fully consent to taking part
- People who are not able to understand or speak the official language used at the research centre where the trial is being run
- People who are currently excluded from another study, or who are already taking part in another trial that involves an intervention
- People who fall into legally protected categories under French public health law — this includes pregnant or breastfeeding women, people held in custody, people hospitalised without their consent, and adults under legal guardianship or protection (confirm with trial site if unsure whether this applies)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Ruben Wanono, MD, CHU de Reims
Phone: +33672448711
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Evaluate the performance of Apneal® in diagnosing sleep apnea-hypopnea syndrome (SAHS)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.